US equities |
NVDA $238.50 ▲+1.94% SPCX $167.08 ▲+5.11% MU $1,063.47 ▼-1.06% TSLA $380.31 ▲+2.62% MSFT $525.53 ▲+1.55% SNDK $1,708.83 ▼-0.65% INTC $117.24 ▼-1.75% META $742.86 ▲+2.03%
FinancialContent

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
Via ACCESS Newswire
News headline image
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Via ACCESS Newswire
News headline image
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
Via ACCESS Newswire
News headline image
Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
Via ACCESS Newswire
News headline image
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Via ACCESS Newswire
News headline image
Zomedica Corp. Announces Transition to OTCQB Venture Market
Via ACCESS Newswire
News headline image
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
Via ACCESS Newswire
News headline image
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
Via ACCESS Newswire
News headline image
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Via ACCESS Newswire
News headline image
Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
Via ACCESS Newswire
News headline image
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
Via ACCESS Newswire
News headline image
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
Via ACCESS Newswire
News headline image
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents
Via ACCESS Newswire
News headline image
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
Via ACCESSWIRE
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging
Via ACCESS Newswire
News headline image
Zomedica and UXR Announce Expanded Distribution Agreement in Canada
Via ACCESS Newswire
News headline image
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
Via ACCESS Newswire
News headline image
Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine
Via ACCESS Newswire
News headline image
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets
Via ACCESS Newswire
News headline image
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
Via ACCESS Newswire
News headline image
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics
Via ACCESS Newswire
News headline image
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
Via ACCESS Newswire
News headline image
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
Via ACCESS Newswire
News headline image
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Via ACCESS Newswire
News headline image
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
Via ACCESS Newswire
News headline image
Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health ↗
Zomedica Corp (AMEX: ZOM) launches 2 new canine assays for its TRUFORMA platform. NT-proBNP test detects heart failure, progesterone test helps with breeding timing. 
Via Benzinga
News headline image
Earnings Scheduled For March 13, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >